Robaxin: Effective Relief for Acute Musculoskeletal Pain
Robaxin
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.00 | $40.00 (0%) | 🛒 Add to cart |
| 20 | $2.25 | $80.00 $45.00 (44%) | 🛒 Add to cart |
| 30 | $1.67 | $120.00 $50.00 (58%) | 🛒 Add to cart |
| 60 | $0.92 | $240.00 $55.00 (77%) | 🛒 Add to cart |
| 90 | $0.67 | $360.00 $60.00 (83%) | 🛒 Add to cart |
| 120 | $0.58 | $480.00 $70.00 (85%) | 🛒 Add to cart |
| 180 | $0.50 | $720.00 $90.00 (88%) | 🛒 Add to cart |
| 270 | $0.44 | $1080.00 $120.00 (89%) | 🛒 Add to cart |
| 360 | $0.42
Best per pill | $1440.00 $150.00 (90%) | 🛒 Add to cart |
Synonyms | |||
Robaxin (methocarbamol) is a centrally acting skeletal muscle relaxant indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions. As an adjunct to rest, physical therapy, and other measures, it works by blocking nerve impulses (or pain sensations) that are sent to the brain, helping to break the cycle of pain and muscle spasm. Its efficacy is well-documented in clinical settings, making it a trusted option for healthcare providers managing acute musculoskeletal pain. This product card provides a comprehensive overview for medical professionals to ensure informed, safe prescribing and patient counseling.
Features
- Active ingredient: Methocarbamol
- Available in 500 mg and 750 mg oral tablets
- Also available in injectable form for hospital use
- Onset of action: Oral—within 30 minutes; Injectable—immediate
- Duration of effect: 4–6 hours per dose
- Excretion: Primarily renal
- Half-life: 1–2 hours
- Pregnancy Category C
- Not scheduled as a controlled substance
Benefits
- Provides rapid relief from acute muscle pain and spasms
- Helps restore mobility and function by reducing muscular hypertonicity
- Supports physical therapy and rehabilitation efforts
- Minimizes the need for higher-dose opioid analgesics in many cases
- Well-tolerated profile with a low incidence of serious adverse effects
- Short half-life allows for flexible dosing and quick discontinuation if needed
Common use
Robaxin is commonly prescribed for the management of acute musculoskeletal pain and spasm resulting from conditions such as muscle strains, sprains, injuries, or inflammatory disorders. It is frequently used in cases of lower back pain, whiplash injuries, and post-operative orthopedic care. It serves as an adjunct to rest, physical therapy, analgesics, and other symptomatic measures. It is not intended for long-term use or chronic conditions; treatment duration is typically short, focusing on the acute phase of musculoskeletal disorders.
Dosage and direction
For adults and children 16 years and older, the initial dose is 1500 mg four times a day for the first 48–72 hours (e.g., 3 x 500 mg tablets QID). For severe conditions, 8 grams per day may be administered under medical supervision. Maintenance dosing can typically be reduced to 1000 mg four times daily, or 750 mg every 4 hours, or 1500 mg three times daily. The maximum recommended daily dose is 8 grams. Tablets should be taken with a full glass of water and may be taken with or without food. Use beyond 2–3 weeks is not recommended unless directed by a physician. For injectable use, dosage is administered by healthcare professionals only, typically at 1–3 grams per day via intramuscular or slow intravenous injection.
Precautions
Use with caution in patients with impaired renal function, as methocarbamol is excreted renally. It may cause drowsiness or dizziness; patients should be advised against operating machinery or driving until they know how the medication affects them. Avoid concomitant use with alcohol or other CNS depressants. Use during pregnancy only if clearly needed and after weighing potential risks. Not recommended for use during lactation. Elderly patients may be more sensitive to effects and require lower dosing. Discontinue if allergic reaction occurs.
Contraindications
Robaxin is contraindicated in patients with a known hypersensitivity to methocarbamol or any component of the formulation. It is also contraindicated in patients with renal impairment severe enough to potentially impact drug excretion. Should not be used in comatose states or in the presence of metabolic acidosis. Not for use in children under 16 years of age unless specifically indicated by a healthcare provider.
Possible side effect
Common side effects may include dizziness, drowsiness, nausea, vomiting, blurred vision, headache, and metallic taste. These are generally mild and transient. Less frequently, hypotension, bradycardia, syncope, and allergic reactions (e.g., urticaria, rash, pruritus) may occur. Rare but serious side effects include anaphylaxis, leukopenia, and seizures. Patients should be monitored and advised to report any persistent or severe adverse reactions.
Drug interaction
Robaxin may enhance the effects of other CNS depressants, including alcohol, benzodiazepines, opioids, sedatives, and tranquilizers—dosage adjustments may be necessary. Concomitant use with MAO inhibitors or tricyclic antidepressants may increase CNS depression. It may also potentiate the effects of neuromuscular blocking agents. Use with caution in patients taking other renally excreted drugs.
Missed dose
If a dose is missed, it should be taken as soon as remembered. However, if it is almost time for the next dose, the missed dose should be skipped and the regular dosing schedule resumed. Doubling the dose is not recommended.
Overdose
Symptoms of overdose may include nausea, vomiting, drowsiness, blurred vision, hypotonia, coma, respiratory depression, and seizures. Management is supportive and symptomatic; there is no specific antidote. Gastric lavage may be considered if ingestion was recent. Monitor vital signs and provide respiratory support if needed. Hemodialysis may be beneficial in severe cases.
Storage
Store at room temperature (20–25°C or 68–77°F), away from light, moisture, and heat. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is intended for medical professionals and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition or medication. Dosage and indications may vary based on individual patient factors and clinical context.
Reviews
Clinical studies and post-marketing surveillance indicate that Robaxin is generally effective and well-tolerated for short-term management of acute musculoskeletal spasm. Many practitioners note its utility in reducing opioid requirements and facilitating earlier mobilization. Some reports highlight drowsiness as a limiting factor in certain patients. Overall, it remains a widely used option within its indicated scope.